<DOC>
	<DOCNO>NCT00668096</DOCNO>
	<brief_summary>The objective study evaluate efficacy tolerability phosphodiesterase type 5 inhibitor ( PDE5 inhibitor ) , vardenafil , broad population subject erectile dysfunction different aetiology severity , previously treat PDE5 inhibitor ; Efficacy safety compare placebo .</brief_summary>
	<brief_title>A Randomised Study Levitra Treat Men With Erections Problems Previously Untreated With Similar Therapy .</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<criteria>Males erectile dysfunction accord National Institute Health ( NIH ) Consensus statement ( inability attain and/or maintain penile erection sufficient satisfactory sexual performance Heterosexual relationship 6 month Partner willing complete TSS Primary hypoactive sexual desire History myocardial infarction , stroke lifethreatening arrhythmia within prior 6 month Nitrate use Other exclusion criterion apply accord Summary Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>PDE5 inhibitor</keyword>
</DOC>